Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Subcutaneous immunoglobulin therapy for inflammatory neuropathy: current evidence base and future prospects.
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.
Efficacy of lower fingolimod doses in the treatment of MS.
Serum antibodies to 25 myelin oligodendrocyte glycoprotein epitopes in multiple sclerosis and neuromyelitis optica: clinical value for diagnosis and disease activity.
Comparison of two commercial ELISA systems for evaluating anti-EBNA1 IgG titers.
Cell-Based Reporter Gene Assay for Therapy-Induced Neutralizing Antibodies to Interferon-Beta in Multiple Sclerosis.
[Pharmaceutical prescription for multiple sclerosis : Evaluation of pharmaceutical consumption at private health insurance.]
NLRP3 Inflammasome and MS/EAE.
Anti-high mobility group box 1 monoclonal antibody ameliorates experimental autoimmune encephalomyelitis.
Sex Disparities in Neuro-Ophthalmologic Disorders.
Nogo Receptor Inhibition Enhances Functional Recovery following Lysolecithin-Induced Demyelination in Mouse Optic Chiasm.
Ion Channels in Neurological Disorders.
Disease-modifying therapies and infectious risks in multiple sclerosis.
Response to letter regarding article 'Fingolimod effects on left ventricular function in multiple sclerosis'.
Lymphomatoid papulosis: A cutaneous lymphoproliferative disorder in a patient on fingolimod for multiple sclerosis.
Role of the Immunogenic and Tolerogenic Subsets of Dendritic Cells in Multiple Sclerosis.
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis.
G protein-coupled receptors as therapeutic targets for multiple sclerosis.
[Characteristics of the autonomous control of cardiac activity in patients with remitting multiple sclerosis.]
In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects.
Stretching the limbs? Tonic spasms in multiple sclerosis.
Inhibition of delta-like ligand 4 decreases Th1/Th17 response in a mouse model of multiple sclerosis.
[Natalizumab in the treatment of patients with relapsing-remitting multiple sclerosis: the preliminary results of the observational program "Sovet"]
A case of acute combined central and peripheral demyelination.

Pages